Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

WCG forms advisory board for gene therapy research
May 2016
SHARING OPTIONS:

PRINCETON, N.J.—WIRB-Copernicus Group (WCG) recently convened the WCG Gene Therapy Advisory Board to advise the company on the latest advances in gene therapy research. The board will offer guidance and strategic counsel for WCG’s oversight of human gene transfer research, which involves coordinating institutional review board and institutional biosafety committee reviews. In addition, this group will also aid WCG in prepping clients to manage increasing volumes of gene therapy research.
 
“Human gene therapy is one of the fastest-growing areas of medical research, and also one of the most promising,” Dr. Donald A. Deieso, chairman and CEO of WCG, said. “The advances made by scientists and clinicians in the field of gene therapy have enabled us to target disease at the genetic level, redefining the concept of precision medicine.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.